Marie Lorraine Chrétien

Suggest Changes
Learn More
PURPOSE Primary plasma cell leukemia (pPCL) is a rare and aggressive malignancy with a poor prognosis. With conventional chemotherapy, patients typically die within 1 year. In all but one of the(More)
  • 1